You are here: Industry Insights > NCI

News List

Neurotrope Announces Agreement for Bryostatin-1 with National Cancer Institute americanpharmaceuticalreview
February 19, 2019
Neurotrope has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) for the research and clinical development of Bryostatin-1.....
Drug Company Payments Over Time May Influence Rx Practices drugs
February 14, 2019
Physicians treating certain cancers who consistently receive payments from a cancer drug's manufacturer are more likely to prescribe that drug instead of other treatments, according to a study published online Feb. 6 in The Oncologist....
NCI awards contract to PACT & Health of Branford, CT, USA expressbpd
September 25, 2017
An integrated platform to screen anti-cancer drugs using high-throughput clonogenic assay will be designed
SillaJen and NCI partner to develop new colorectal cancer treatment pharmaceutical-technology
August 21, 2017
Korean-based SillaJen has entered a cooperative research and development agreement (CRADA) with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), US, to develop a new combination therapy for colorectal cancer (CRC).
Research by NCI determines necessary genes for cancer immunotherapy cphi-online
August 09, 2017
The research could accelarate the advancement of a new category of drugs.

Previous page 1 2 Next page